Evidence map›Paper›PMID 40888353›Full record

ArticleJournal of chemical information and modeling2025

Prediction of Activity and Selectivity Profiles of Sigma Receptor Ligands Using Machine Learning Approaches.

Lisa Lombardo, Verena Battisti, Thierry Langer, Rosaria Gitto, Laura De Luca

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lisa LombardoDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences (CHIBIOFARAM), University of Messina, Viale Ferdinando D'Alcontres 13, I-98166 Messina, Italy.
Verena BattistiDepartment of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.ORCID 0000-0001-9794-366X
Thierry LangerDepartment of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.ORCID 0000-0002-5242-1240
Rosaria GittoDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences (CHIBIOFARAM), University of Messina, Viale Ferdinando D'Alcontres 13, I-98166 Messina, Italy.ORCID 0000-0003-0002-2253
Laura De LucaDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences (CHIBIOFARAM), University of Messina, Viale Ferdinando D'Alcontres 13, I-98166 Messina, Italy.ORCID 0000-0003-0614-5713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sigma (σ) receptors (SRs) have emerged as important therapeutic targets due to their roles in various biological pathways. They are classified into two subtypes: S1R, primarily distributed in the central nervous system and related to neuroprotection and neurodegenerative diseases, and S2R mainly expressed in cancer cells and associated with cell proliferation and apoptosis, as well as in neurons. Although S1R and S2R exhibit structural differences in receptor architecture and assembly, they share similar binding site features and ligand recognition mechanisms. This similarity underscores the importance of identifying selective ligands for therapeutic design, especially given the distinct physiological functions of these receptors. In this project, we developed three distinct machine learning (ML) approaches based on classification, regression, and multiclassification models to predict the activity and selectivity profiles of SR ligands. High-quality data sets were curated from public and in-house source; in turn, the data sets were systematically organized and processed for each workflow. Models were built using molecular descriptors and fingerprints, including Mordred, RDKit, ECFP4, ECFP6, and MACCS keys, and trained with various ML algorithms such as extra trees, random forest, support vector machine,

Indexed as

Machine LearningReceptors, sigmaHumansLigandsLigandsReceptors, sigma

Identifiers

PMID40888353
PMCPMC12458689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.